Alternatives to Haplotype Labs

AI-native biotech pairing 20+ petabytes of cellular experiments with population genetics to find causal drug targets

Tempus is an AI precision oncology platform that pairs tumor DNA/RNA sequencing with a 7M+ de-identified clinical record library for treatment and trial

Exscientia now lives inside Recursion — an AI drug discovery engine built on automated wet labs and a 50+ PB dataset.

Open-source, self-hosted AI research assistant for drug discovery — molecular property prediction, virtual screening and PK/PD modeling on your own hardware.

Per-plant crop intelligence platform from Alphabet's X, now acquired by Driscoll's and John Deere

Owkin's K Pro is an autonomous AI scientist agent that informs biopharma R&D, clinical trial and portfolio decisions.

Clinical-stage AI drug discovery company running a wet-and-dry lab-in-the-loop engine with 2M weekly experiments and a 50+ PB phenomics dataset

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.

Silico is Goodfire's interpretability agent for understanding, debugging, and controlling the internals of your AI models

Clinical-stage biotech designing highly selective small-molecule drugs for oncology, immunology, and metabolic disease through partnership-led discovery.

Generative AI drug discovery suite covering target ID, molecule design, biologics engineering and clinical trial prediction.

Insight Booster automates enterprise-scale research, analysis, and report generation with agentic AI workflows.

Oncology real-world evidence platform turning patient data into AI-assisted cancer research insights.

All-in-human AI foundation models that predict brain activity and therapy response for CNS drug programs

Iktos pairs generative AI with robotic lab automation to compress small-molecule drug discovery.

AI Voice of the Customer analytics that turns unstructured customer feedback into measurable business outcomes

Renamed: Deep 6 AI was acquired by Tempus AI in March 2025 and its trial matching folded into Tempus.

Physics-based simulation plus AI for molecular discovery across drug and materials design.

Independent A–F carbon credit ratings and market intelligence for professional carbon buyers, developers, and investors.

Cloud ELN, LIMS, and AI platform that unifies biotech R&D data for discovery teams.

FDA-cleared AI for cancer pathology: prostate, breast, GI and pan-cancer detection on H&E slides, plus Virchow foundation models for research.

Cloud-based medical imaging platform that turns MRI, CT, and PET scans into regulatory-cleared quantitative imaging biomarkers.

AI-guided protein engineering that co-optimizes binding, stability, activity, and expression using your own wet-lab data.

Cellino builds closed-loop, AI-guided bioprocessing hardware for personalized cell therapy manufacturing.

BenevolentAI applies a decade-built biomedical knowledge graph to drug target discovery and repurposing for biopharma R&D teams.

Finster AI is an agentic finance platform that automates data synthesis, analysis, and PowerPoint-ready output for investment banking, asset management, and

PathAI is an enterprise digital pathology platform for diagnostic accuracy and biopharma drug development.

Clinical-stage TechBio company using cellular imaging and AI to discover drugs, with a Phase 1 MALT1 inhibitor and a Genentech neuroscience collaboration.

Dotmatics Luma: agentic AI that plans, executes, and completes R&D data analysis, report generation and platform configuration for multimodal scientific

Agentic AI platform that watches food and beverage signals across 59 markets and hands F&B teams finished, cited trend briefs.